![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Chinese FDA Approves Profound’s Sonalleve
Chinese FDA Approves Profound’s Sonalleve
May 10, 2018
Profound Medical received an approval from China’s FDA for its Sonalleve, a therapeutic platform used to perform ablation of diseased tissue.
Sonalleve offers women with uterine fibroids a non-invasive therapy that avoids performing hysterectomies in invasive surgery and hospitalization.
The device combines real-time magnetic resonance imaging and thermometry with thermal ultrasound to remove tissue without making incisions.
Upcoming Events
-
21Oct